New! Sign up for our free email newsletter.
Science News
from research organizations

Cannabis compound acts as an antibiotic

Date:
February 26, 2020
Source:
American Chemical Society
Summary:
Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges. However, scientists haven't discovered a new class of antibiotics in more than 30 years. Now, researchers have uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol (CBG), which helped control methicillin-resistant Staphylococcus aureus (MRSA) infections in mice.
Share:
FULL STORY

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges. However, scientists haven't discovered a new class of antibiotics in more than 30 years. Now, researchers reporting in ACS Infectious Diseases have uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol (CBG), which helped control methicillin-resistant Staphylococcus aureus (MRSA) infections in mice.

For centuries, cannabis plants have been used in folk medicine. Today, scientists are only beginning to investigate whether different cannabis compounds could be used to treat a variety of diseases. Early studies have shown that some cannabinoids can slow the growth of gram-positive bacteria, such as S. aureus, but not gram-negative bacteria, such as E. coli. Eric Brown and colleagues wanted to test the antibacterial properties of several cannabinoids against both MRSA and gram-negative bacteria.

The researchers tested the antibacterial activity of 18 cannabis-derived molecules, including cannabidiol (CBD), tetrahydrocannabinol (THC) and CBG, against MRSA. They also tested the ability of these substances to prevent the formation of biofilms on surfaces and to kill dormant "persistor" MRSA that are highly resistant to antibiotics. CBG performed the best in these tests, so the researchers chose to study it further. When they treated MRSA-infected mice with CBG, the compound worked as well as vancomycin, a powerful antibiotic. The researchers discovered that CBG targets the cell membrane of gram-positive bacteria, and by itself, it is not effective against gram-negative bacteria, which have an additional outer membrane. However, they found that if they gave CBG with another drug that pokes holes in this outer membrane, CBG could reach the inner membrane and kill gram-negative bacteria.


Story Source:

Materials provided by American Chemical Society. Note: Content may be edited for style and length.


Journal Reference:

  1. Maya A. Farha, Omar M. El-Halfawy, Robert T. Gale, Craig R. MacNair, Lindsey A. Carfrae, Xiong Zhang, Nicholas G. Jentsch, Jakob Magolan, Eric D. Brown. Uncovering the Hidden Antibiotic Potential of Cannabis. ACS Infectious Diseases, 2020; DOI: 10.1021/acsinfecdis.9b00419

Cite This Page:

American Chemical Society. "Cannabis compound acts as an antibiotic." ScienceDaily. ScienceDaily, 26 February 2020. <www.sciencedaily.com/releases/2020/02/200226130527.htm>.
American Chemical Society. (2020, February 26). Cannabis compound acts as an antibiotic. ScienceDaily. Retrieved April 17, 2024 from www.sciencedaily.com/releases/2020/02/200226130527.htm
American Chemical Society. "Cannabis compound acts as an antibiotic." ScienceDaily. www.sciencedaily.com/releases/2020/02/200226130527.htm (accessed April 17, 2024).

Explore More

from ScienceDaily

MORE COVERAGE

RELATED STORIES